Dr. Hannawi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 W. Grand BLVD
K14
Detroit, MI 48202
Summary
- Bashar Hannawi, MD, is a cardiology specialist based in Detroit, MI. He holds expertise in heart failure & transplantation, which he backed up with a fellowship in Advanced Heart Failure and Transplant Cardiology from the Methodist Hospital in Houston, where he also completed his residency in Internal Medicine. He is currently an MD at Henry Ford Hospital. Dr. Hannawi has gained substantial experience in areas including transplant cardiology, congestive heart failure, and VAD management. His contributions to the field are visible through the numerous publications he has authored, on topics such as outcomes of ECMO as bridge to heart transplant and evaluation of SOMAscan in patients with congestive heart failure.
Education & Training
- Methodist Hospital (Houston)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2018 - 2019
- Methodist Hospital (Houston)Residency, Internal Medicine, 2012 - 2015
- University of Tichreen Faculty of MedicineClass of 2010
Certifications & Licensure
- MI State Medical License 2019 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis.Isabel S Griffin, Dallas J Smith, Pallavi Annambhotla, Jeremy A W Gold, Luis Ostrosky-Zeichner
Transplant Infectious Disease. 2024-10-01 - Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients.Joseph Debbs, Bashar Hannawi, Edward Peterson, Hongsheng Gui, Nicole Zeld
Journal of Cardiovascular Translational Research. 2023-12-01 - Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation.Robert Kenneth Sims 4th, Nina Srour, Lamees I El Nihum, Bashar Hannawi, Raquel Araujo-Gutierrez
The International Journal of Artificial Organs. 2022-11-01
Journal Articles
- Reticulated Platelets: Changing Focus from Basics to OutcomesBashar Hannawi, Neal S Kleiman, Yousef Hannawi, Thrombosis and Haemostasis
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: